Dramatic changes are expected when the proposals to repair, replace and repeal federal health law is implemented across the states. From insurance subsidies, health exchanges and Medicaid expansion, there are many areas where these changes will be implemented. Policymakers have to find financing sources for the new initiatives and make payment reforms. The role and responsibilities of states in this field must be clearly defined. Fixing health care is not easy but if it is not done now, it will keep deteriorating. At present, healthcare is not in the best condition and does not stand up to the levels of health care available in some other developed countries.
There is need to develop new strategies to deal with these issues. The days of conducting business as usual are over. The rising costs of health care services are an issue for both health care providers and patients. Governments face problems because even after spending a large amount of money on subsidized healthcare, many people still cannot afford medical services. Governments have to reduce errors, enforce guidelines, improve medical record keeping, and provide health care services even to people who cannot afford it. Those who are ready to pay for it must receive the value and quality they expect from their medical service providers.
The healthcare laws must be organized around the needs of the patients. However, it cannot undermine the interests of healthcare professionals, hospitals and governments. This transformation in health care is not going to come without some drastic changes in existing policies. The planned changes must be measured and properly implemented for effective results.
Healthcare industry needs funds for research and clinical trials. Such investments cannot be left solely in the hands of private drugs manufacturers and investors. There are many institutions that have achieved remarkable achievements in the health care industry through innovative policy changes. These policies must be studied carefully before fixing health care laws. The policymakers have to protect the interests of not only the patients but also other stakeholders like healthcare professionals, hospitals, clinics and drug manufacturers.